Advertisement
Advertisement
Business /

Companies

Related Topics:
Banking & finance

Yiwu market owner eyes Hong Kong IPO to support overseas expansion

Hong Kong listing plan comes after the company reported net profit of 4.2 billion yuan for 2025, up 36.8 per cent from a year earlier.

Hangzhou ‘Six Little Dragons’ member Manycore seeks US$130m from Hong Kong IPO

Everest’s US$250 million buy signals rising global appetite for China biotech

Sovereign wealth funds from Singapore and Abu Dhabi join Chinese state capital as cross-border biotech licensing reaches record highs.

Advertisement
Advertisement
Advertisement

Global drug makers face pricing pressure as China targets affordable healthcare

As pharmaceutical firms navigate China’s aggressive pricing reforms, their profits could be squeezed further this year.

A pharmaceutical production line in Meishan, China. Photo: Costfoto/NurPhoto via Getty Images
Help preserve 120 years of quality journalism.
SUPPORT NOW